Genenta to Appoint Stephen Squinto, Experienced Biotech Executive and Investor, as Chairman

    NEXT STORY
    Immunocore’s tebentafusp demonstrates superior overall survival compared to investigator’s choice in a Phase 3 clinical trial of patients with previously untreated metastatic uveal melanoma
    PREV STORY
    Powerful, Inspirational Voices on the Frontlines of the AIDS and Covid-19 Pandemics Speak Out on World AIDS Day – December 1st
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene Announces Clinical Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

    author_avatar
    NASDAQ Market News

    Aduro Biotech Reports Second Quarter 2018 Financial Results

    BERKELEY, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today ...

    author_avatar
    NASDAQ Market News

    Genespire appoints Jörn Aldag as Chairman of the Board of Directors

    author_avatar
    NASDAQ Market News